Ontex Group NV

DB:OT7 Stock Report

Market Cap: €603.7m

Ontex Group Valuation

Is OT7 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of OT7 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: OT7 (€7.26) is trading below our estimate of fair value (€16.97)

Significantly Below Fair Value: OT7 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for OT7?

Key metric: As OT7 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for OT7. This is calculated by dividing OT7's market cap by their current earnings.
What is OT7's PE Ratio?
PE Ratio17.4x
Earnings€34.60m
Market Cap€603.74m

Price to Earnings Ratio vs Peers

How does OT7's PE Ratio compare to its peers?

The above table shows the PE ratio for OT7 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average32.9x
BEI Beiersdorf
37.4x12.7%€27.6b
4919 Milbon
27.2x10.6%JP¥111.5b
MARICO Marico Bangladesh
13.8xn/a৳73.3b
301507 Hangzhou Minsheng Healthcare
53.2xn/aCN¥4.7b
OT7 Ontex Group
17.4x34.9%€603.7m

Price-To-Earnings vs Peers: OT7 is good value based on its Price-To-Earnings Ratio (17.4x) compared to the peer average (32.9x).

Price to Earnings Ratio vs Industry

How does OT7's PE Ratio compare vs other companies in the European Personal Products Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
OT7 17.4xIndustry Avg. 22.0xNo. of Companies3PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: OT7 is good value based on its Price-To-Earnings Ratio (17.4x) compared to the European Personal Products industry average (22x).

Price to Earnings Ratio vs Fair Ratio

What is OT7's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

OT7 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio17.4x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate OT7's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst OT7 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€7.26
€11.20
+54.2%
18.6%€13.83€8.29n/a6
Nov ’25€7.64
€11.20
+46.5%
18.6%€13.83€8.29n/a6
Oct ’25€9.01
€11.25
+24.8%
19.2%€13.83€8.10n/a6
Sep ’25€9.04
€11.22
+24.1%
19.9%€13.83€8.10n/a6
Aug ’25n/a
€11.11
0%
20.1%€13.83€8.10n/a6
Jul ’25n/a
€11.11
0%
20.1%€13.83€8.10n/a6
Jun ’25€9.11
€11.11
+21.9%
20.1%€13.83€8.10n/a6
May ’25n/a
€10.99
0%
20.7%€13.83€8.10n/a6
Apr ’25n/a
€10.16
0%
20.7%€13.83€8.10n/a6
Mar ’25n/a
€10.16
0%
20.7%€13.83€8.10n/a6
Feb ’25n/a
€9.86
0%
23.3%€13.83€7.50n/a6
Jan ’25n/a
€9.86
0%
23.7%€13.83€7.20n/a6
Dec ’24n/a
€9.86
0%
23.7%€13.83€7.20n/a6
Nov ’24€6.57
€9.86
+50.0%
23.7%€13.83€7.20€7.646
Oct ’24n/a
€9.91
0%
23.4%€13.83€7.10€9.016
Sep ’24€7.32
€9.56
+30.7%
24.1%€13.83€7.10€9.047
Aug ’24€7.59
€10.26
+35.2%
36.7%€18.71€7.10n/a7
Jul ’24n/a
€9.74
0%
47.4%€18.71€6.00n/a5
Jun ’24n/a
€9.54
0%
44.4%€18.71€6.00€9.116
May ’24n/a
€10.24
0%
42.0%€18.71€6.80n/a5
Apr ’24n/a
€10.24
0%
42.0%€18.71€6.80n/a5
Mar ’24€7.14
€9.42
+31.9%
45.4%€18.71€6.00n/a6
Feb ’24n/a
€9.42
0%
45.4%€18.71€6.00n/a6
Jan ’24n/a
€9.82
0%
41.3%€18.71€6.00n/a7
Dec ’23€6.22
€9.82
+57.9%
41.3%€18.71€6.00n/a7
Nov ’23€5.84
€9.83
+68.3%
41.2%€18.71€6.00€6.577

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

L'Oréal

€173.8b

Through its subsidiaries, manufactures and sells cosmetic products for women and men worldwide.

LOR

€324.85

7D

-3.6%

1Y

-23.0%

Revolution Beauty Group

UK£43.7m

Engages in the development, production, wholesale, and retail of beauty products in the United Kingdom, the United States, and internationally.

8UA

UK£0.16

7D

-3.7%

1Y

-45.5%

Reynolds Consumer Products

US$5.7b

Produces and sells products in cooking, waste and storage, and tableware product categories in the United States and internationally.

3ZT

US$25.00

7D

0%

1Y

4.2%